“…Although tumours may favour the appearance of RCVS, it has also been described that surgical and non-surgical oncologic treatment may induce vascular changes at the brain level that lead to the disease (Mathis et al, 2017;Duke et al, 2018;Katada et al, 2018). In the case of radiotherapy, particularly in brain tumours, it can lead to dynamic vascular lesions and generate pathologies such as RCVS, SMART syndrome (stroke-like migraine attacks after radiation therapy), Moya-Moya disease or even haemorrhagic cerebrovascular attack (Duke et al, 2018;Katada et al, 2018). Similarly, there is an association between treatment with chemotherapy and the appearance of vasospasm at the cerebral level, as is the case of the chemotherapy regimen with oxaliplatin and capecitabine, which has been linked as an aetiology of subsequent reversible leukoencephalopathy syndrome presented with RCVS in up to 38% of cases (Mathis et al, 2017;Duke et al, 2018;Katada et al, 2018).…”